|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 27, 2016 ) Publisher's, 'Dementia Associated with Alzheimer Disease - Pipeline Review, H1 2016', provides an overview of the Dementia Associated with Alzheimer's disease pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Dementia Associated With Alzheimer's Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Dementia Associated With Alzheimer's Disease and features dormant and discontinued projects.
Publisher's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Other Key Points in Report:
- The report provides a snapshot of the global therapeutic landscape of Dementia Associated With Alzheimer's Disease
- The report reviews pipeline therapeutics for Dementia Associated With Alzheimer's Disease by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Dementia Associated With Alzheimer's Disease therapeutics and enlists all their major and minor projects
- The report assesses Dementia Associated With Alzheimer's Disease therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Dementia Associated With Alzheimer's Disease
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001242069/sample
Table of Content: An Overview
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Dementia Associated With Alzheimer's Disease Overview 8
Therapeutics Development 9
Pipeline Products for Dementia Associated With Alzheimer's Disease - Overview 9
Pipeline Products for Dementia Associated With Alzheimer's Disease - Comparative Analysis 10
Dementia Associated With Alzheimer's Disease - Therapeutics under Development by Companies 11
Dementia Associated With Alzheimer's Disease - Therapeutics under Investigation by Universities/Institutes 12
Dementia Associated With Alzheimer's Disease - Pipeline Products Glance 13
Late Stage Products 13
Clinical Stage Products 14
Early Stage Products 15
Unknown Stage Products 16
Dementia Associated With Alzheimer's Disease - Products under Development by Companies 17
Dementia Associated With Alzheimer's Disease - Products under Investigation by Universities/Institutes 18
Dementia Associated With Alzheimer's Disease - Companies Involved in Therapeutics Development 19
Adamas Pharmaceuticals, Inc. 19
AgeneBio Inc. 20
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001242069/discount
Amarantus Bioscience Holdings, Inc. 21
Boehringer Ingelheim GmbH 22
Chase Pharmaceuticals Corporation 23
Eisai Co., Ltd. 24
FORUM Pharmaceuticals Inc. 25
H. Lundbeck A/S 26
MediPost Co., Ltd. 27
Neurodyn Inc. 28
Dementia Associated With Alzheimer's Disease - Therapeutics Assessment 29
Assessment by Monotherapy Products 29
Assessment by Target 30
Assessment by Mechanism of Action 32
Assessment by Route of Administration 34
Assessment by Molecule Type 36
Drug Profiles 38
(donepezil hydrochloride + memantine hydrochloride ER) - Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
BI-409306 - Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001242069/buy/2000
About Us:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us:
Email: sales@reportsweb.com
Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
